Healthcare [ 10/13 ] | Medical Devices [ 104/159 ]
NASDAQ | Common Stock
TransMedics Group, Inc., a commercial-stage medical technology company, engages in transforming organ transplant therapy for end-stage organ failure patients in the United States and internationally.
The company offers Organ Care System (OCS), a portable organ perfusion, optimization, and monitoring system that utilizes its proprietary and customized technology to replicate near-physiologic conditions for donor organs outside of the human body.
Its OCS includes OCS LUNG for the preservation of standard criteria donor lungs for double-lung transplantation; OCS Heart, a technology for preservation of DBD donor hearts deemed unsuitable due to limitations of cold storage and for ex vivo reanimation, functional monitoring, and beating-heart preservation of donation-after-circulatory-death hearts; and OCS Liver for the preservation of DBD and DCD of donor livers.
The company also developed national OCS program, a turnkey solution for outsourced organ retrieval; and provides OCS organ management and logistics services, including aviation and ground transportation, and other coordination activity.
The company was founded in 1998 and is headquartered in Andover, Massachusetts.
| Reported Date | EPSChange YoY | EstimateSurprise |
|---|---|---|
| Feb 26, 24 | 0.12 Increased by +157.14% | -0.03 Increased by +500% |
| Nov 6, 23 | -0.78 Decreased by -212% | -0.16 Decreased by -387.5% |
| Aug 3, 23 | -0.03 Increased by +92.68% | -0.13 Increased by +76.92% |
| May 1, 23 | -0.08 Increased by +78.95% | -0.25 Increased by +68% |
| Feb 22, 23 | -0.21 Increased by +54.35% | -0.3 Increased by +30% |
| Nov 3, 22 | -0.25 Increased by +46.81% | -0.41 Increased by +39.02% |
| Aug 1, 22 | -0.41 Decreased by -5.13% | -0.35 Decreased by -17.14% |
| May 3, 22 | -0.38 Decreased by -31.03% | -0.38 |
| Fiscal ending date | RevenueChange YoY | IncomeChange YoY | ProfitChange YoY |
|---|---|---|---|
| Sep 30, 23 | 66.43 M Increased by +158.65% | -25.42 M Decreased by -242.34% | Decreased by -38.27% Decreased by -32.35% |
| Jun 30, 23 | 52.47 M Increased by +155.66% | -1 M Increased by +91.31% | Decreased by -1.91% Increased by +96.6% |
| Mar 31, 23 | 41.55 M Increased by +161.68% | -2.64 M Increased by +75.04% | Decreased by -6.34% Increased by +90.46% |
| Dec 31, 22 | 31.38 M Increased by +224.52% | -6.72 M Increased by +46.95% | Decreased by -21.42% Increased by +83.65% |
| Sep 30, 22 | 25.68 M Increased by +378.27% | -7.43 M Increased by +42.71% | Decreased by -28.91% Increased by +88.02% |
| Jun 30, 22 | 20.52 M Increased by +151.14% | -11.52 M Decreased by -8.01% | Decreased by -56.15% Increased by +56.99% |
| Mar 31, 22 | 15.88 M Increased by +125.15% | -10.56 M Decreased by -33.41% | Decreased by -66.51% Increased by +40.75% |
| Dec 31, 21 | 9.67 M Increased by +26.76% | -12.67 M Decreased by -100.73% | Decreased by -131.03% Decreased by -58.35% |